Education
About Us
Working with TipRanks
Follow Us
Carlos Paya Insider Profile
4 Followers
Carlos Paya, President & CEO, Director at Immune Design, holds 7.17K shares in Vaxcyte (Ticker: PCVX), holds 126.84K shares in Standard BioTools (Ticker: LAB), holds 0.00 shares in Mallinckrodt (Ticker: MNKKQ).
Carlos Paya Immune Design (IMDZ)President & CEO, Director
Immune Design (IMDZ)
President & CEO, Director
Not Ranked
Carlos Paya has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Stock:
Mallinckrodt
(MNKKQ)
(MNKKQ)
Rating:Informative Sell
Date:Mar 16, 2021 - Mar 16, 2022
Return:+68.10%
The most profitable trade made by Carlos Paya
Carlos Paya's Trading History
Immune Design
Apr 04, 2019
―
Uninformative Sell
208.12K
$0.00
Standard BioTools
Jun 16, 2023
Director
Uninformative Buy
―
$147.14K
Mallinckrodt
Mar 16, 2021
―
Informative Sell
6.65K
$0.00
Vaxcyte
Dec 10, 2024
Director
Uninformative Buy
―
$510.72K
List of latest transactions for each holding click on a transaction to see Carlos Paya's performance on stock
You May Also Like
Carlos Paya insider profile FAQ
What is the percentage of profitable transactions made by Carlos Paya?
The percentage of profitable transactions made by Carlos Paya is ―.
What is the average return per transaction made by Carlos Paya?
The average return per transaction made by Carlos Paya is ―.
What stocks does Carlos Paya hold?
Carlos Paya holds: IMDZ, LAB, MNKKQ, PCVX stocks.
What was Carlos Paya’s latest transaction?
Carlos Paya latest transaction was an Uninformative Buy of ―.
What was Carlos Paya's most profitable transaction?
Carlos Paya’s most profitable transaction was an Informative Sell of MNKKQ stock on March 16, 2021. The return on the trade was 68.10%.
What is Carlos Paya's role in Immune Design?
Carlos Paya's role in Immune Design is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.